Cargando…

A Novel Combretastatin A‐4 Derivative, AC‐7700, Shows Marked Antitumor Activity against Advanced Solid Tumors and Orthotopically Transplanted Tumors

AC‐7700, a novel combretastatin A‐4 derivative, suppresses the growth of solid tumors by inhibiting tumor perfusion. We evaluated the antitumor activity of AC‐7700 on solid tumors in two experimental models, an advanced tumor model (murine colon 26 (c26) adenocarcinoma, colon 38 (c38) adenocarcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nihei, Yukio, Suga, Yasuyo, Morinaga, Yoshihiro, Ohishi, Kazuo, Okano, Akira, Ohsumi, Koji, Hatanaka, Toshihiro, Nakagawa, Ryusuke, Tsuji, Takashi, Akiyama, Yukio, Saito, Sachiko, Hori, Katsuyoshi, Sato, Yasufumi, Tsuruo, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1999
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926154/ https://www.ncbi.nlm.nih.gov/pubmed/10551333 http://dx.doi.org/10.1111/j.1349-7006.1999.tb00850.x

Ejemplares similares

Antitumor Effects due to Irreversible Stoppage of Tumor Tissue Blood Flow: Evaluation of a Novel Combretastatin A‐4 Derivative, AC7700
por: Hori, Katsuyoshi, et al.
Publicado: (1999)

Evaluation of Antivascular and Antimitotic Effects of Tubulin Binding Agents in Solid Tumor Therapy
por: Nihei, Yukio, et al.
Publicado: (1999)

Microvascular mechanisms by which the combretastatin A-4 derivative AC7700 (AVE8062) induces tumour blood flow stasis
por: Hori, K, et al.
Publicado: (2003)

Induction of tumour blood flow stasis and necrosis: a new function for epinephrine similar to that of combretastatin A-4 derivative AVE8062 (AC7700)
por: Hori, K, et al.
Publicado: (2004)

A novel combretastatin A-4 derivative, AC7700, strongly stanches tumour blood flow and inhibits growth of tumours developing in various tissues and organs
por: Hori, K, et al.
Publicado: (2002)

Tumor‐selective Blood Flow Decrease Induced by an Angiotensin Converting Enzyme Inhibitor, Temocapril Hydrochloride
por: Hori, Katsuyoshi, et al.
Publicado: (2000)

Platelet aggregation in the formation of tumor metastasis
por: Tsuruo, Takashi, et al.
Publicado: (2008)

In vivo Analysis of Tumor Vascularization in the Rat
por: Hori, Katsuyoshi, et al.
Publicado: (1990)

Tumor Growth Suppression of Pancreatic Cancer Orthotopic Xenograft Model by CEA-Targeting CAR-T Cells
por: Sato, Osamu, et al.
Publicado: (2023)

Characterization of Heterogeneous Distribution of Tumor Blood Flow in the Rat
por: Hori, Katsuyoshi, et al.
Publicado: (1991)

Expression of P‐Glycoprotein mRNA in Human Gastric Tumors
por: Sugimoto, Yoshikazu, et al.
Publicado: (1989)

Genome-wide data from two early Neolithic East Asian individuals dating to 7700 years ago
por: Siska, Veronika, et al.
Publicado: (2017)

Expression Behavior of 85‐kDa Membrane Protein in Adriamycin‐resistant Tumor Cells and the Inhibition of Human Tumor Growth in Athymic Mice by MRK‐20 Monoclonal Antibody against the Protein
por: Ishii, Shigetaka, et al.
Publicado: (1993)

Cytotoxicity Studies of Novel Combretastatin and Pterostilbene Derivatives
por: Jakubowska, Joanna, et al.
Publicado: (2014)

Combretastatin-Inspired Heterocycles as Antitubulin Anticancer Agents
por: Hura, Neha, et al.
Publicado: (2018)

Novel Selective Estrogen Receptor Ligand Conjugates Incorporating Endoxifen-Combretastatin and Cyclofenil-Combretastatin Hybrid Scaffolds: Synthesis and Biochemical Evaluation
por: Kelly, Patrick M., et al.
Publicado: (2017)

Nanoscale quantification of the biophysical characterization of combretastatin A-4-treated tumor cells using atomic force microscopy
por: Li, Yanchun, et al.
Publicado: (2017)

In vivo effects of mutant RHOA on tumor formation in an orthotopic inoculation model
por: Nishizawa, Takashi, et al.
Publicado: (2019)

Antitumor Activity of ME2303, a Fluorine‐containing Anthracycline, against Human Tumors Implanted in Nude Mice
por: Tsuruo, Takashi, et al.
Publicado: (1989)

A Combretastatin-Mediated Decrease in Neutrophil Concentration in Peripheral Blood and the Impact on the Anti-Tumor Activity of This Drug in Two Different Murine Tumor Models
por: Bohn, Anja Bille, et al.
Publicado: (2014)

An organometallic analogue of combretastatin A-4 and its apoptosis-inducing effects on lymphoma, leukemia and other tumor cells in vitro
por: Abodo Onambele, Liliane, et al.
Publicado: (2022)

Tumors of the mediastinum
por: Shimosato, Yukio
Publicado: (1997)

Effects of Intravenous Infusion of Dopamine on Tumor Blood Flow in Rat Subcutis
por: Tanda, Shigeru, et al.
Publicado: (1994)

Inhibition of Multidrug‐resistant Human Tumor Growth in Athymic Mice by Anti‐P‐glycoprotein Monoclonal Antibodies
por: Tsuruo, Takashi, et al.
Publicado: (1989)

Fluctuations in Tumor Blood Flow under Normotension and the Effect of Angiotensin II‐induced Hypertension
por: Hori, Katsuyoshi, et al.
Publicado: (1991)

Prevention of cancer recurrence in tumor margins by stopping microcirculation in the tumor and tumor–host interface
por: Hori, Katsuyoshi, et al.
Publicado: (2014)

Detection and Quantitation of Circulating Tumor Cell Dynamics by Bioluminescence Imaging in an Orthotopic Mammary Carcinoma Model
por: Sasportas, Laura Sarah, et al.
Publicado: (2014)

Novel indole-bearing combretastatin analogues as tubulin polymerization inhibitors
por: Kumar, Sunil, et al.
Publicado: (2013)

Combretastatin A4 disodium phosphate-induced myocardial injury
por: Tochinai, Ryota, et al.
Publicado: (2016)

Combretastatins: An Overview of Structure, Probable Mechanisms of Action and Potential Applications
por: Karatoprak, Gökçe Şeker, et al.
Publicado: (2020)

Orthotopic models of pediatric brain tumors in zebrafish
por: Eden, Christopher J., et al.
Publicado: (2014)

Expression of 85‐kDa Protein of Adriamycin‐resistant Tumor Cells during Hematopoietic Differentiation of THP‐1 and HEL Cells
por: Ishii, Shigetaka, et al.
Publicado: (1992)

Analysis of second- and third-line antihypertensive treatments after initial therapy with an angiotensin II receptor blocker using real-world Japanese data
por: Hiroi, Shinzo, et al.
Publicado: (2016)

Folate Receptor-Mediated Enhanced and Specific Delivery of Far-Red Light-Activatable Prodrugs of Combretastatin A-4 to FR-Positive Tumor
por: Nkepang, Gregory, et al.
Publicado: (2014)

Comparison of the Effects of Intravenously Bolus‐administered Endothelin‐1 and Infused Angiotensin II on the Subcutaneous Tumor Blood Flow in Anesthetized Rats
por: Tanda, Shigeru, et al.
Publicado: (1991)

Combretastatin-A4 disrupts neovascular development in non-neoplastic tissue
por: Griggs, J, et al.
Publicado: (2001)

The interaction with tubulin of a series of stilbenes based on combretastatin A-4.
por: Woods, J. A., et al.
Publicado: (1995)

The anti-angiogenic effect and novel mechanisms of action of Combretastatin A-4
por: Su, Min, et al.
Publicado: (2016)

Synthesis and Cytotoxic Activity of a New Group of Heterocyclic Analogues of the Combretastatins
por: Lipeeva, Alla V., et al.
Publicado: (2014)

Identification of Novel Diagnostic Markers for Malignant Pleural Mesothelioma Using a Reverse Translational Approach Based on a Rare Synchronous Tumor
por: Naka, Tomoaki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tp8tlgp2qjegc48go7b07k5629